1300 I Street NW
Suite 1200 East
Washington, DC 20005
Telephone: (202) 496-4800
Fax: (202) 496-4324
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
Rule/Notice/NOFO: Notice of Proposed Policy Statement Regarding the Applicability of FTA’s Drug and Alcohol Testing Program to Transportation Network Companies (Docket No. FTA–2024–0020)
Federal Register/Notice: govinfo.gov
Type of Requirement: Notice. Comments due February 13, 2025. Late-filed comments will be considered to the extent practicable.
Description: This notice proposes to clarify FTA’s policy on the applicability of FTA’s drug and alcohol testing program to transportation network companies. FTA proposes to update the Shared Mobility frequently asked questions, published in 2016 on FTA’s website, to correct an error that has resulted in the misapplication of what is commonly known as the taxicab exception and clarify when the exception applies. FTA seeks comment from all interested parties. After review and consideration of the comments, FTA will issue a final notice announcing the policy statement and the revised FAQs.
How is it enforced by FTA, DOT, Direct grant requirement, triennial review or other? N/A
Is there a cost or time impact to grantees (best estimate): Yes
APTA Comment/Letter: Completed Comments
APTA Staff Advisor: Stacie Tiongson, stiongson@apta.com